Skip to main content
. 2020 Feb 1;8(1):60. doi: 10.3390/vaccines8010060

Table 7.

Clinical and economic outcomes per 1000 Internationally Adopted Children (IAC), by disease (ELISA method).

VPD Strategy Total Cost of the Strategy (Euro) IAC 1 Protected (N) Avoided Cases (N) Possible Cases (N) Cost Per Protected Children (Euro)
Measles Comparator 17,445.68 960.83 0.0501 0.0018 18.16
Strategy 1 18,635.40 993.72 0.0516 0.0003 18.75
Strategy 2 25,452.38 989.50 0.0514 0.0005 25.72
Rubella Comparator 18,245.20 962.78 0.00507 0.00013 18.95
Strategy 1 17,461.95 998.46 0.00520 0.00001 17.49
Strategy 2 25,452.38 995.13 0.00518 0.00003 25.58
Mumps Comparator 9482.39 915.02 0.0664 0.0067 10.36
Strategy 1 19,453.99 925.55 0.0641 0.0050 21.02
Strategy 2 25,452.38 875.00 0.0639 0.0091 29.09
Varicella Comparator 23,945.44 930.43 3.5382 0.2688 25.74
Strategy 1 21,390.65 966.00 3.6623 0.1446 22.14
Strategy 2 25,452.38 934.25 3.5566 0.2503 27.24
All VPDs together Comparator 69,118.72 3769.06 3.6598 0.28 18.34
Strategy 1 76,941.99 3883.72 3.7832 0.15 19.81
Strategy 2 101,809.50 3793.88 3.6771 0.26 26.84

Note: IAC 1 = Internationally adopted children; comparator = vaccine based on vaccination records; strategy 1 = vaccine based on serology; strategy 2 = vaccine to all IAC.